Abstract
Herpesvirus infections are a major cause of morbidity and mortality in immunocompromised patients. Human cytomegalovirus (HCMV) is the causative agent in a wide spectrum of clinical diseases in these individuals (Weller, 1981). After organ or bone marrow transplantation, nearly all patients under certain conditions develop HCMV infections (Meyers, Fluornoy, and Thomas, 1986). Among allogeneic bone marrow transplant recipients, 15 to 20 percent will develop HCMV pneumonitis, with the mortality rate as high as 90 percent. Varicella-zoster virus (VZV), another member of the herpesvirus family, is also a significant pathogen for immunocompromised patients (Gershon, 1980; Straus, et al., 1988). For example, in children with leukemia or lymphoma, about 30 percent of those with varicella will develop pneumonitis, which is associated with a 7 percent mortality rate (Balfour, 1988). Although cell-mediated immunity is critical in recovery from HCMV and VZV infections, passive immunization with gammaglobulin has been shown both to prevent and to modify infection (Winston et al., 1982; Condie and O’Reilly, 1984; Paryani et al., 1984; Winston et al., 1987). Furthermore, high-dose gammaglobulin therapy in conjunction with administration of a new anti-viral agent, ganciclovir, has been shown effective in treating HCMV pneumonitis (Emanuel et al., 1988a; Reed et al., 1988; Schmidt et al., 1988). For these reasons, substantial efforts have been devoted to the production of human monoclonal antibodies (Humabs) to HCMV and VZV. Ultimately, these Humabs should replace human plasma as a source of antibodies in the prevention and treatment of HCMV and VZV infections.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Balfour, H. H. (1988) Am. J. Med. 85, 68–73.
Banks, T., Huo, B., Kousoulas, K., Spaete, R., Pachl, C., and Pereira, L. (1989) J. Gen. Virol. 70, 979–985.
Bowden, R. A., Sayers, M., Flournoy, N., Newton, N., Banaji, M., Thomas, E. D., and Meyers, J. D. (1986) N. Engl. J. Med., 314 1006–1010.
Celis, E., Zurawski, R., and Chang, T. W., (1984) Proc. Natl. Acad. Sci. USA 8, 6846–6850.
Condie, R. M., and O’Reilly, R. J. (1984) Am. J. Med. 76 (3A), 134–141.
Davison, A. J., Edson, C. M., Ellis, R. W., Forghani, B., Gilden, D., Grose, C., Keller, P. M., Vafai, A., Wroblewska, Z., and Yamanishi, K. (1986) J. Virol. 57, 1195–1197.
Emanuel D., Cunningham, I., Jules-Elysee, K., Brochstein, J. A., Kernan, N. A., Laver, J., Stover, D., White, D. A., Fels, A., Polsky, B., Castro-Malaspina, H., Peppard, J. R., Bartus, P., Hammerling, U., and O’Reilly, R. J. (1988a) Ann. Intern. Med. 109, 777–782.
Emanuel D., Peppard, J., Chelini, J., Hammerling, U., and O’Reilley, R. (1988b) in Clinical Applications of Monoclonal Antibodies (Hubbard, R., and Marks, V., eds.) pp. 139–148, Plenum Press, New York.
Forman, S. J., Zaia, J. A., Clark, B. R., Wright, C. L., Mills, B. J., Pottathil, R., Racklin, B. C., Gallagher, M. T., Welte, K., and Blume, K. G. (1985) J. Immunol. 134, 3391–3395.
Foung, S. K. H., and Perkins, S. (1989) J. Immunol. Methods 116, 117–122.
Foung, S. K. H., Perkins, S., Bradshaw, P., Rowe, J., Rabin, L. B., Reyes, G. R., and Lennette, E. T. (1989) J. Infect. Dis. 159, 436–443.
Foung, S. K. H., Perkins, S., Koropchak, C., Fishwild, D. M., Wittek, A. E., Engleman, E. G., Grumet, F. C., and Arvin, A. M. (1985) J. Infect. Dis. 152, 280–285.
Friedrichs, W. E., and Grose, C. (1986) J. Virol. 57, 155–164.
Geballe, A. P., Leach, F. S., and Mocarski, E. S. (1986) J. Virol. 57, 864–874.
Gershon, A. A. (1980) Rev. Infect. Dis. 2, 393–407.
Gershon, A. A. (1985) in The Herpes Viruses, Vol. 4 (Roizman, B., and Lopez, C., eds.) pp. 313–326, Plenum Press, New York.
Gershon, A. A., and Steinberg, S. P. (1989) N. Engl. J. Med. 320, 892–897.
Gibson, W. (1983) Virology 128, 391–406.
Hayaka, Y., Torigoe, S., Shiraki, K., Yamanishi, K., and Takahashi, M. (1984) J. Infect. Dis. 149, 956–963.
Huynh, T. V. R., Young, R., and Davis, R. W. (1984) in DNA Cloning Techniques: A Practical Approach (Glover, D., ed.) pp. 49–78, IRL Press, Oxford.
Irmiere, A., and Gibson, W. (1983) Virology 130, 118–133.
James, K., and Bell, G. T. (1987) J. Immunol. Methods 100, 5–40.
Jungi, T. W., Santer, M., Lerch, P. G., and Barandun, S. (1986) Vox Sang. 51, 18–26.
Klatt, E. C., and Shibata, D. (1988) Arch. Pathol. Lab. Med. 112, 540–544.
LoBuglio, A. E., Wheeler, R. H., Trang, J., Haynes, A., Rogers, K., Harvey, E. B., Sun, L., Ghrayeb, J., and Khazaeli, M. B. (1989) Proc. Natl. Acad. Sci. USA 86, 4220–4224.
Meyers, J. D., Leszczynki, J., Zaia, J. A., Flournoy, N., Newton, B., Snydman, D. R., Wright, G. G., Levin, N. J., and Thomas, E. D. (1983) Ann. Intern. Med. 98, 442–446.
Meyers, J. D., Flournoy, N., and Thomas, E. D. (1986) J. Infect. Dis. 153, 478–488.
Meyers, J. D. (1988) Am. J. Med. 85, 102–106.
Miller, R. A., Oseroff, A. R., Stratte, P. T., and Levy, R. (1983) Blood 62, 988–995.
Mocarski, E. S., Pereira, L., and Michael, N. (1985) Proc. Natl. Acad. Sci. USA 82, 1266–1270.
Nose, M., and Wigzell, H. (1983) Proc. Natl. Acad. Sci. USA 80, 6632–6636.
Ozaki, S., and Berzofsky, J. A. (1987) J. Immunol. 138, 4133–4142.
Pande, H., Baak, S. W., Riggs, A. D., Clark, B. R., Shively, J. E., and Zaia, J. (1984) Proc. Natl. Acad. Sci. USA 81, 4965–4969.
Paryani, S. G., Arvin, A. M., Koropchak, C. M., Wittek, A. E., Amylon, M. D., Dobkin, M. B., and Budinger, M. D. (1984) Am. J. Med. 76, 124–127.
Pereira, L., Hoffman, M., Tatsuno, M., and Dondero, D. (1984) Virology 139, 73–86.
Quinnan, G. V., Masur, H., Rook, A. H., Armstrong, G., Frederick, W. R., Epstein, J., Manischewitz, J. F., Macher, A. M., Jackson, L., Ames, J., Smith, H. A., Parker, M., Pearson, G. R., Parrillo, J., Mitchell, C., and Straus, S. E. (1984) JAMA 252, 72–77.
Quinnan, G. V., and Rook, A. H. (1984) Birth Defects 20, 245–261.
Rasmussen, L., Mullenax, J., Nelson, R., and Merigan, T. C. (1985) J. Virol. 55, 274–280.
Reed, E. C., Bowden, R. A., Dandliker, P. S., Lilleby, K. E., and Meyers, J. D. (1988) Ann. Intern. Med. 109, 783–788.
Ripalti, A., Landini, M. P., Mocarski, E. S., and La Placa, M. (1989) J. Gen. Virol. 70, 1247–1251.
Schmidt, G. M., Kovacs, A., Zaia, J. A., Horak, D. A., Blume, K. G., Nademanee, A. P., O’Donnell, M. R., Snyder, D. S., and Forman, S. J. (1988) Transplantation 46, 905–907.
Schroff, R. W., Foon, K. A., Beatty, S. M., Oldham, R. K., and Morgan, A. C. (1985) Cancer Res. 45, 879–885.
Shepp, D. H., Dandliker, P. S., and Meyers, J. D. (1988) Am. J. Med. 85, 96–98.
Spaete, R. R., Thayer, R. M., Probert, W. S., Masiarz, F. R., Chamberlain, S. H., Rasmussen, L., Merigan, T. C., and Pachl, C. (1988) Virology 167, 207–225.
Stinski, M. F. (1977) J. Virol. 23, 751–767.
Straus, S. E., Ostrove, J. M., Inchauspe, G., Felser, J. M., Freifeld, A., Croen, K. D., and Sawyer, M. H. (1988) Ann. Intern. Med. 108, 221–237.
Takahashi, M., Asano, Y., Kamiya, H., and Baba, K. (1986) in Human Herpes Virus Infections: Pathogenesis, Diagnosis, and Treatment (Lopez, C., and Roizman, B., eds.) pp. 247–258, Raven Press, New York.
Uemura, Y., Yokoyama, K., Nishida, M., and Suyama, T. (1989) Vox Sang. 57, 1–3.
Vilde, J. L., Bricaire, E., Leport, C., Renaudie, M., and Brun-Vezinet, F. (1986) J. Virol. 20, 127–134.
Weller, T. H. (1981) in The Human Herpesviruses, (Nahmias, A. J., Dowalle, W. R., and Schinaze, R., eds.) pp. 20–30, Elsevier, New York.
Williams, P. E., Yap, P. L., Gillon, J., Crawford, R. J., Urbaniak, S. J., and Galea, G. (1989) Vox Sang. 57, 15–18.
Winston, D. J., Pollard, R. B., Ho, W. G., Gallagher, J. G., Rasmussen, L. E., Huang, S. N. Y., Lin, C. H., Gosset, T. G., Merigan, T. C., and Gale, R. P. (1982) Ann. Intern. Med. 97, 11–18.
Winston, D. J., Ho, W., Lin, C. H., Bartoni, K., Budinger, M. D., Gale, R. P., and Champlin, R. E. (1987) Ann. Intern. Med. 106, 12–18.
Young, R. A., and Davis, R. W. (1983) Proc. Natl. Acad. Sci. USA 80, 1194–1198.
Zimmerman, U. (1986) Rev. Physiol. Biochem. Pharmacol. 105, 175–256.
Editor information
Copyright information
© 1990 Stockton Press
About this chapter
Cite this chapter
Foung, S.K.H., Bradshaw, P.A., Emanuel, D. (1990). Uses of Human Monoclonal Antibodies to Human Cytomegalovirus and Varicella-Zoster Virus. In: Borrebaeck, C.A.K., Larrick, J.W. (eds) Therapeutic Monoclonal Antibodies. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-11894-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-349-11894-6_11
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-11896-0
Online ISBN: 978-1-349-11894-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)